As this paper noted yesterday, Biohackers World drew nearly 2,000 attendees to its Los Angeles event on March 28-29 -- a record for the organization. [1] The next events, scheduled for New York in June and Chicago later in the year, are scaling dramatically: organizers have listed 10,000 tickets at approximately $500 each, reflecting a conference circuit that has outgrown boutique wellness and entered the territory of consumer expos. [2]

The market validates the ambition. The global longevity industry is projected to surpass $740 billion in 2026, according to a market report published in February. [3] UBS has separately forecast longevity spending at $8 trillion by 2030. [4] The biohacking market alone -- a subset covering wearables, supplements, and self-optimization protocols -- is valued at roughly $45 billion this year and growing at 19 percent annually. [5]

What began as a Silicon Valley subculture of self-experimenters tracking sleep scores and cycling peptides now has its own convention circuit, its own venture capital pipeline, and its own tension between evidence-based medicine and the $500-a-ticket aspiration of living forever. The conferences are where those tensions negotiate in real time.

-- NORA WHITFIELD, Chicago